Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2003

Study Completion Date

August 31, 2005

Conditions
Pancreatic Cancer
Interventions
DRUG

perifosine

Trial Locations (10)

10466

MBCCOP-Our Lady of Mercy Cancer Center, The Bronx

46601

CCOP - Northern Indiana CR Consortium, South Bend

55416

CCOP - Metro-Minnesota, Saint Louis Park

55805

CCOP - Duluth, Duluth

55905

Mayo Clinic Cancer Center, Rochester

58122

CCOP - Merit Care Hospital, Fargo

61801

CCOP - Carle Cancer Center, Urbana

76508

CCOP - Scott and White Hospital, Temple

50309-1016

CCOP - Iowa Oncology Research Association, Des Moines

02111

Tufts - New England Medical Center, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00059982 - Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer | Biotech Hunter | Biotech Hunter